Trial
NCT00739960
Safety Study of Abatacept to Treat Refractory Sarcoidosis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
Bristol-Myers Squibb
Condition
Sarcoidosis
Intervention
Abatacept
Why stopped
Funding has been pulled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-23